Sirana enters into collaborative research agreement with Pfizer
Companies will combine to investigate a novel treatment for a rare bone disease
30th June 2022
Companies will combine to investigate a novel treatment for a rare bone disease
30th June 2022
Centre will accelerate drug development and enable precision health solutions
30th June 2022
Scientists will trial a programme of exercise conditioning and psychological therapy for people diagnosed with the condition
29th June 2022
AVA6000 is a novel form of doxorubicin that has been modified using Avacta’s delivery platform to improve safety
29th June 2022
The mobile clinics will support communities with limited or no access to vaccines and other health services
28th June 2022
New data will be released at the International Society on Thrombosis and Haemostasis Congress
28th June 2022
CHMP returns positive opinion on Rinvoq for the treatment of adults with active non-radiographic axial spondyloarthritis
27th June 2022
Cosentyx receives expanded approvals in EU for use in childhood arthritic conditions
27th June 2022
COVID-19 Beta-containing vaccine provides 75.1% efficacy in participants previously infected with coronavirus
24th June 2022
MHRA extends UCB’s therapy for the treatment of partial-onset seizures
24th June 2022
Global surveillance systems show that recorded cases do not include any deaths
23rd June 2022
The company has renewed its pledge to eliminate neglected tropical diseases and malaria over five years
23rd June 2022
Novartis receives approval from the European Commission for Tabrecta for the treatment of non-small cell lung cancer
22nd June 2022
The MS Society responds as MS therapy Fampyra is rejected
22nd June 2022
Eplontersen significantly improved patient-reported quality of life following successful research
21st June 2022